CD7 CAR T bridging to allo‐HSCT in R/R T‐ALL: A case report-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

CD7 CAR T bridging to allo‐HSCT in R/R T‐ALL: A case report

Published:2022-07-21 Issue: Volume: Page:
ISSN:1397-3142
Container-title:Pediatric Transplantation
language:en
Short-container-title:Pediatric Transplantation

Author:

Fanqiao Meng¹²^ORCID,Chen Xiuqiong³⁴,Ren Xiaotong¹,Li Lijuan¹

Affiliation:

1. Department of Hematology Tianjin Medical University General Hospital Tianjin China

2. Department of Bone Marrow Transplantation Beijing Boren Hospital Beijing China

3. Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer Tianjin China

4. Key Laboratory of Cancer Prevention and Therapy Tianjin China

Publisher

Wiley

Subject

Transplantation,Pediatrics, Perinatology and Child Health

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/petr.14367

Reference17 articles.

1. PSEN1‐selective gamma‐secretase inhibition in combination with kinase or XPO‐1 inhibitors effectively targets T cell acute lymphoblastic leukemia;Govaerts I;J Hematol Oncol,2021

2. Targeting serine hydroxymethyltransferases 1 and 2 for T‐cell acute lymphoblastic leukemia therapy;Pikman Y;Leukemia,2022

3. Current and emerging therapeutic approaches for T‐cell acute lymphoblastic leukaemia;Pocock R;Br J Haematol,2021

4. Hypodiploidy in a pediatric patient of T‐cell acute lymphoblastic leukemia: a case report;Stefaniak M;BMC Med Genomics,2021

5. A phase I study of CAR‐T bridging HSCT in patients with acute CD19(+) relapse/refractory B‐cell leukemia;Ma Y;Oncol Lett,2020

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Demethylating agents in combination with CD7-targeted CAR-T for the successful treatment of a case with mixed-phenotype acute leukemia relapsed after allogeneic hematopoietic stem cell transplantation: A Case Report;Frontiers in Immunology;2023-09-28

2. Targeted therapy and immunotherapy for T cell acute lymphoblastic leukemia/lymphoma;Annals of Hematology;2023-05-25

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3